EMA begins second rolling review of a COVID-19 vaccine
The European Medicines Agency (EMA) has begun a ‘rolling review’ of data on a vaccine for COVID-19, which is being … read more »
EMA reaffirms commitment to independence and transparency for COVID-19 treatments and medicines
The European Medicines Agency (EMA) has explained, in an open letter that it will consider products for the current pandemic … read more »
Analysis proves EU safety system robust
The European Medicines Agency (EMA) has produced a report into its incident management plan (EU-IMP) showing it has functioned effectively … read more »
EMA and HMA launch consultation on joint network strategy
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have launched a consultation into their joint network strategy … read more »
EMA removes scientific advice fees for some academic work
The European Medicines Agency (EMA) will work to encourage development of medicines for rare diseases by waiving the fees it … read more »
EMA launches 2019 annual report
The annual report of the European Medicines Agency (EMA) for 2019 has been released, giving insights into the work done … read more »
Analysis of EMA Q&A for medicinal products during the COVID-19 pandemic
MAP has been provided with an analysis of the EMA COVID-19 Q&A reported on recently. The European Commission recently published … read more »
NIH announces public-private partnership against COVID-19
The US National Institutes of Health (NIH) and Foundation for the NIH (FNIH) have launched a collaboration between industry and … read more »
EMA published Q&A on coronavirus regulatory requirements
In order to better explain the flexibilities introduced to manage the coronavirus pandemic, the European Commission (EC), European Medicines Agency … read more »
EMA publishes Regulatory Science Strategy to 2025
The European Medicines Agency (EMA) has launched its Regulatory Science Strategy to 2025 to ensure its regulatory work is optimised … read more »
